← Back
Data updated: Mar 29, 2026
PIRAMAL CRITICAL
OncologyMetabolic
Generics
PIRAMAL CRITICAL is a generic drug manufacturer focused on Oncology, Metabolic.
1994
Since
11
Drugs
-
Trials
63
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
ROCURONIUM BROMIDE 2026-01-06
GLYCOPYRROLATE 2025-12-23
ISOFLURANE 2025-11-04
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
1 drugs
Metabolic 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (6)
Discontinued (5)
Company Info
- First Approval
- 1994-07-29
- Latest
- 2025-10-16
- Applications
- 12